Insulinoma historical perspective

Jump to: navigation, search

Insulinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Insulinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

X-ray

Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Insulinoma historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Insulinoma historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Insulinoma historical perspective

CDC on Insulinoma historical perspective

Insulinoma historical perspective in the news

Blogs on Insulinoma historical perspective

Directions to Hospitals Treating Insulinoma

Risk calculators and risk factors for Insulinoma historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2], Parminder Dhingra, M.D. [3]

Overview

In 1869, pancreatic islet cells were discovered by Paul Langerhans. The first adenoma of islets was discovered by Nicholls in 1902. Insulin was first discovered by Banting and Best in 1922. Association between hyperinsulinism and functional islet tumor was described in 1926 by Wilder. In 1927, the insulinoma was first described in Mayo clinic which was dissected in 1929 in Toronto. In 1929, the first surgical cure was performed by Roscoe Graham. In 1935, Whipple suggested a diagnostic criterion for the diagnosis of insulinoma called as Whipple's triad.

Historical Perspective

Discovery

  • Pancreatic islet cells were first described by Paul Langerhans in 1869 when he was still a medical student.
  • In 1902, the first adenoma of pancreatic islets was discovered by Nicholls.[1]
  • Insulin was first discovered by Frederick Banting and Charles Best in 1922 from a dog’s pancreas.
  • The association between hyperinsulinism and functional islet tumor was made in 1926 by Wilder-et-al after a surgery on a person who had hypoglycemia and found an islet cell cancer with liver metastasis.[2]
  • In 1927, William J Mayo was the first to discover the association between hyperinsulinism and a functional pancreatic islet cell tumor. In 1927 the insulinoma was first described in Mayo clinic which was dissected in 1929 in Toronto.[1]
  • In 1929, the first surgical cure was performed by Roscoe Graham.[3]

Landmark Events in the Development of Treatment Strategies

  • William J Mayo did the first operation for insulinoma in 1927 and found it to be unresectable. Two years later, Roscoe Graham successfully completed the first surgical cure of an islet cell tumor.
  • In 1935, Whipple's triad was developed by Virginia Kneeland Frantz and Allen O. Whipple to diagnose insulinoma.

Famous Cases

References

  1. 1.0 1.1 Stamatakos M, Safioleas C, Tsaknaki S, Safioleas P, Iannescu R, Safioleas M (2009). "Insulinoma: a rare neuroendocrine pancreatic tumor". Chirurgia (Bucur). 104 (6): 669–73. PMID 20187464.
  2. Wilder, Russell M.; Allan, Frank N.; Power, M. H.; Robertson, H. E. (1927). "CARCINOMA OF THE ISLANDS OF THE PANCREAS". Journal of the American Medical Association. 89 (5): 348. doi:10.1001/jama.1927.02690050014007. ISSN 0002-9955.
  3. 3.0 3.1 Whipple AO, Frantz VK (1935). "ADENOMA OF ISLET CELLS WITH HYPERINSULINISM: A REVIEW". Ann. Surg. 101 (6): 1299–335. PMC 1390871. PMID 17856569.


Linked-in.jpg